Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy

被引：27
作者：
Ben-Baruch, Adit [1 ]
机构：
[1] Tel Aviv Univ, George S Wise Fac Life Sci, Shmunis Sch Biomed & Canc Res, Tel Aviv, Israel
来源：
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金：
以色列科学基金会;
关键词：
cancer; personalized therapy; tumor necrosis factor a/TNFa; TNFR1; TNFR2; TNF-ALPHA; BREAST-CANCER; RHEUMATOID-ARTHRITIS; MOLECULAR-CLONING; RECOMBINANT HUMAN; PHASE-II; CELL-DEATH; T-CELLS; EXPRESSION; RECEPTOR;
D O I：
10.3389/fimmu.2022.903679
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页数：6
相关论文
共 94 条
[1]   STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[2]   Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance [J].
Antoon, James W. ;
Lai, Rongye ;
Struckhoff, Amanda P. ;
Nitschke, Ashley M. ;
Elliott, Steven ;
Martin, Elizabeth C. ;
Rhodes, Lyndsay V. ;
Yoon, Nam Seung ;
Salvo, Virgilio A. ;
Shan, Bin ;
Beckman, Barbara S. ;
Nephew, Kenneth P. ;
Burow, Matthew E. .
SCIENTIFIC REPORTS, 2012, 2
[3]   Haematopoietic malignancies in rheumatoid arthritis:: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists [J].
Askling, J ;
Fored, CM ;
Baecklund, E ;
Brandt, L ;
Backlin, C ;
Ekbom, A ;
Sundström, C ;
Bertilsson, L ;
Cöster, L ;
Geborek, P ;
Jacobsson, LT ;
Lindblad, S ;
Lysholm, J ;
Rantapää-Dahlqvist, S ;
Saxne, T ;
Klareskog, L ;
Feltelius, N .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1414-1420
[4]   Rheumatoid arthritis and malignant lymphomas [J].
Baecklund, E ;
Askling, J ;
Rosenquist, R ;
Ekbom, A ;
Klareskog, L .
CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (03) :254-261
[5]  
BALKWILL FR, 1986, CANCER RES, V46, P3990
[6]   Tumour necrosis factor and cancer [J].
Balkwill, Frances .
NATURE REVIEWS CANCER, 2009, 9 (05) :361-371
[7]   The chemokine system and cancer [J].
Balkwill, Frances R. .
JOURNAL OF PATHOLOGY, 2012, 226 (02) :148-157
[8]   Chemotherapy Shifts the Balance in Favor of CD8+TNFR2+TILs in Triple-Negative Breast Tumors [J].
Baram, Tamir ;
Erlichman, Nofar ;
Dadiani, Maya ;
Balint-Lahat, Nora ;
Pavlovski, Anya ;
Meshel, Tsipi ;
Morzaev-Sulzbach, Dana ;
Gal-Yam, Einav Nili ;
Barshack, Iris ;
Ben-Baruch, Adit .
CELLS, 2021, 10 (06)
[9]   Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy [J].
Baram, Tamir ;
Rubinstein-Achiasaf, Linor ;
Ben-Yaakov, Hagar ;
Ben-Baruch, Adit .
FRONTIERS IN ONCOLOGY, 2021, 10
[10]   Targeted bioactivity of membrane-anchored TNF by an antibody-derived TNF fusion protein [J].
Bauer, S ;
Adrian, N ;
Williamson, B ;
Panousis, C ;
Fadle, N ;
Smerd, J ;
Fettah, I ;
Scott, AM ;
Pfreundschuh, M ;
Renner, C .
JOURNAL OF IMMUNOLOGY, 2004, 172 (06) :3930-3939
12345678910